Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study

This publication has 22 references indexed in Scilit:

• Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 gy)
  International Journal of Radiation Oncology*Biology*Physics, 2002
• The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on radiation therapy oncology group 9406
  Seminars in Radiation Oncology, 2002
• Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer
  Urology, 2001
• Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer
  Journal of Clinical Oncology, 2000
• Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE
  Urology, 1999
• Radiotherapy for High Grade Clinically Localized Adenocarcinoma of the Prostate
  Journal of Urology, 1996
• Re: The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer, by A. W. Partin, J. Yoo, H. B. Carter, J. D. Pearson, D. W. Chan, J. I. Epstein and P. C. Walsh, J. Urol., 150: 110-114, 1993
  Journal of Urology, 1993